Cite
HARVARD Citation
Van de Velde, C. et al. (n.d.). Optimal duration of extended letrozole treatment after 5 years of adjuvant endocrine therapy; results of the randomized phase III IDEAL trial (BOOG 2006–05). European journal of cancer. pp. S9-. [Online].